Federal Register / Vol. 74, No. 114 / Tuesday, June 16, 2009 / Notices 28509 

Southwest Laboratories, 4625 E. Cotton 

Center Boulevard, Suite 177, Phoenix, 

AZ 85040, 602–438–8507/800–279– 

0027. 

St. Anthony Hospital Toxicology 

Laboratory, 1000 N. Lee St., 

Oklahoma City, OK 73101, 405–272– 

7052. 

Sterling Reference Laboratories, 2617 

East L Street, Tacoma, Washington 

98421, 800–442–0438. 

Toxicology & Drug Monitoring 

Laboratory, University of Missouri 

Hospital & Clinics, 301 Business Loop 

70 West, Suite 208, Columbia, MO 

65203, 573–882–1273. 

Toxicology Testing Service, Inc., 5426 

N.W. 79th Ave., Miami, FL 33166, 

305–593–2260. 

US Army Forensic Toxicology Drug 

Testing Laboratory, 2490 Wilson St., 

Fort George G. Meade, MD 20755– 

5235, 301–677–7085. 

The following laboratory voluntarily 

withdrew from the NLCP on May 30, 

2009: 

Diagnostic Services, Inc., dba DSI, 

12700 Westlinks Drive, Fort Myers, 

FL 33913, 239–561–8200/800–735– 

5416. 

*The Standards Council of Canada 

(SCC) voted to end its Laboratory 

Accreditation Program for Substance 

Abuse (LAPSA) effective May 12, 1998. 

Laboratories certified through that 

program were accredited to conduct 

forensic urine drug testing as required 

by U.S. Department of Transportation 

(DOT) regulations. As of that date, the 

certification of those accredited 

Canadian laboratories will continue 

under DOT authority. The responsibility 

for conducting quarterly performance 

testing plus periodic on-site inspections 

of those LAPSA-accredited laboratories 

was transferred to the U.S. HHS, with 

the HHS’ NLCP contractor continuing to 

have an active role in the performance 

testing and laboratory inspection 

processes. Other Canadian laboratories 

wishing to be considered for the NLCP 

may apply directly to the NLCP 

contractor just as U.S. laboratories do. 

Upon finding a Canadian laboratory to 

be qualified, HHS will recommend that 

DOT certify the laboratory (Federal 

Register, July 16, 1996) as meeting the 

minimum standards of the Mandatory 

Guidelines published in the Federal 

Register on April 13, 2004 (69 FR 

19644). After receiving DOT 

certification, the laboratory will be 

included in the monthly list of HHScertified laboratories and participate in 

the NLCP certification maintenance 

program. 

Dated: June 8, 2009. 

Elaine Parry, 

Director, Office of Program Services, 

SAMHSA. 

[FR Doc. E9–14084 Filed 6–15–09; 8:45 am] 

BILLING CODE 4160–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Numbers NIOSH–083 Supplied Air 

Respirators, NIOSH 148 Air Fed Ensembles, 

NIOSH–168 Total Inward Leakage (for 

respirators other than filtering facepieces 

and halfmasks)] 

Notice of Public Meeting To Discuss 

NIOSH’s Respirator Standards 

Development Efforts 

Authority: 29 U.S.C. 651 et seq. 

AGENCY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of a public meeting. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and prevention (CDC), will 

conduct a public meeting to discuss 

current respirator standards 

development projects for Supplied Air 

Respirators (SAR); Air Fed Ensembles; 

and Total Inward Leakage (TIL) for 

respirators other than filtering 

facepieces and halfmasks. There will be 

an opportunity for discussion following 

NIOSH’s presentations and an 

accompanying poster session. 

Public Meeting Time and Date: 8:30 

a.m. to 5 p.m., September 17, 2009. Onsite registration will be held beginning 

at 7:45 a.m. 

Place: Hyatt Regency Pittsburgh 

International Airport, 1111 Airport 

Boulevard, Pittsburgh, PA 15231. 

Interested parties should make hotel 

reservations directly with the Hyatt 

Regency Pittsburgh International 

Airport by calling (800) 233–1234, 

before the cut-off date of September 2, 

2009. You must reference the NIOSH 

room block to receive the special group 

rate of $114.00 per night that has been 

negotiated for meeting guests. 

Status: The meeting will be open to 

the public, limited only by the space 

available. The meeting room 

accommodates approximately 200 

people. 

Instructions: Requests to make 

presentations at the public meeting 

should be mailed to the NIOSH Docket 

Office, Robert A. Taft Laboratories, MS– 

C34, 4676 Columbia Parkway, 

Cincinnati, OH 45226. Requests may 

also be submitted by telephone (513) 

533–8611, facsimile (513) 533–8285, or 

e-mailed to niocindocket@cdc.gov. All 

requests to present should contain the 

name, address, telephone number, and 

relevant business affiliations of the 

presenter, topic of the presentation, and 

the approximate time requested for the 

presentation. Oral presentations should 

be limited to 15 minutes. 

After reviewing the requests for 

presentations, NIOSH will notify the 

presenter that his/her presentation is 

scheduled. If a participant is not present 

when their presentation is scheduled to 

begin, the remaining participants will be 

heard in order. At the conclusion of the 

meeting, an attempt will be made to 

allow presentations by any scheduled 

participants who missed their assigned 

times. Attendees who wish to speak but 

did not submit a request for the 

opportunity to make a presentation may 

be given this opportunity at the 

conclusion of the meeting, at the 

discretion of the presiding officer. 

This meeting will also be using 

Audio/LiveMeeting Conferencing, 

remote access capabilities where 

interested parties may listen in and 

review the presentations over the 

internet simultaneously. Parties 

remotely accessing the meeting will 

have the opportunity to ask questions 

during the open comment period. To 

register to use this capability, please 

contact the National Personal Protective 

Technology Laboratory(NPPTL), Policy 

and Standards Development Branch, 

Post Office Box 18070, 626 Cochrans 

Mill Road, Pittsburgh, PA 15236, 

telephone (412) 386–5200, facsimile 

(412) 386–4089. This option will be 

available to participants on a first come, 

first serve basis and is limited to the 

first 50 participants. 

Background: NIOSH, National 

Personal Protective Technology 

Laboratory (NPPTL), will present 

information to attendees concerning the 

development of the concepts being 

considered regarding updated 

performance criteria for the various 

classes of respirators in 42 Code of 

Federal Regulations, Part 84. 

Participants will be given an 

opportunity to ask questions and to 

present individual comments that they 

may wish to have considered. 

FOR FURTHER INFORMATION CONTACT: 

Jonathan Szalajda, NPPTL, Policy and 

Standards Development Branch, Post 

Office Box 18070, 626 Cochrans Mill 

Road, Pittsburgh, PA 15236, telephone 

mstockstill on PROD1PC66 with NOTICES

28510 Federal Register / Vol. 74, No. 114 / Tuesday, June 16, 2009 / Notices 

(412) 386–5200, facsimile (412) 386– 

4089, E-mail npptlevents@cdc.gov. 

Reference: Information regarding 

documents that will be discussed at the 

meeting may be obtained from the 

NIOSH Web site using the following 

link: http://www.cdc.gov/niosh/review/ 

public/using the docket numbers listed 

in this notice. 

Dated: June 5,2009. 

James D. Seligman, 

Chief Information Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–14085 Filed 6–15–09; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Einstein 

Aging Study. 

Date: July 15, 2009. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Room 2C212, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: William Cruce, PhD., 

Scientific Review Officer, National Institute 

on Aging, Scientific Review Branch, Gateway 

Building 2C–212, 7201 Wisconsin Ave., 

Bethesda, MD 20814, 301–402–7704, 

crucew@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Restless Legs 

Syndrome. 

Date: July 16, 2009. 

Time: 10 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Room 2C212, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: William Cruce, PhD., 

Scientific Review Officer, National Institute 

on Aging, Scientific Review Branch, Gateway 

Building 2C–212, 7201 Wisconsin Ave., 

Bethesda, MD 20814, 301–402–7704, 

crucew@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Early 

Alzheimer’s Disease. 

Date: July 29, 2009. 

Time: 2 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Room 2C212, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: William Cruce, PhD., 

Scientific Review Officer, National Institute 

on Aging, Scientific Review Branch, Gateway 

Building 2C–212, 7201 Wisconsin Ave., 

Bethesda, MD 20814, 301–402–7704, 

crucew@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: June 9, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–14088 Filed 6–15–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Health Promotion and Disease 

Prevention Announcement Type: New 

Cooperative Agreement Funding 

Opportunity Number: HHS–2009–IHS– 

HPDP–0001 Catalog of Federal 

Domestic Assistance Number: 93.443 

Key Dates: 

Application Deadline Date: July 17, 

2009. 

Application Review Date: July 27, 

2009. 

Application Notification: July 28, 

2009. 

Earliest Anticipated Start Date: 

August 3, 2009. 

I. Funding Opportunity Description 

The Indian Health Service (IHS) 

announces a cooperative agreement for 

Health Promotion and Disease 

Prevention (HP/DP). This Program is 

authorized under the authority of the 

Public Health Service Act section 

301(a); Snyder Act, 25 U.S.C. 13; the 

Transfer Act, 42 U.S.C. 2001; and the 

Indian Health Care Improvement Act, 25 

U.S.C. 1621(b), et seq., as amended. This 

Program is described under 93.443 in 

the Catalog of Federal Domestic 

Assistance (CFDA). 

The purpose of the program is to 

enable American Indian/Alaska Native 

(AI/AN) communities to enhance and 

expand health promotion and reduce 

chronic disease by: increasing physical 

activity, avoiding the use of tobacco and 

alcohol, and improving nutrition to 

support healthier AI/AN communities 

through innovative and effective 

community, school, clinic and work site 

health promotion and chronic disease 

prevention programs. The IHS HP/DP 

Initiative focuses on enhancing and 

expanding health promotion and 

chronic disease prevention to reduce 

health disparities among AI/AN 

populations. The initiative is fully 

integrated with the Department of 

Health and Human Services (HHS) 

Initiatives ‘‘Healthy People 2010.’’ 

Potential applicants may obtain a 

printed copy of Healthy People 2010, 

(Summary Report No. 017–001–00549– 

5) or CD–ROM, Stock No. 017–001– 

00549–5, through the Superintendent of 

Documents, Government Printing 

Office, P.O. Box 371954, Pittsburgh, PA 

15250–7945, (202) 512–1800. You may 

also access this information at the 

following Web sites: http:// 

www.healthypeople.gov/Publications 

and http://www.healthierus.gov/. 

The HP/DP Initiative targets 

cardiovascular disease, cancer, obesity, 

and underage drinking prevention and 

intervention efforts in AI/AN 

communities. Focus efforts include 

enhancing and maintaining personal 

and behavioral factors that support 

healthy lifestyles such as making 

healthier food choices, avoiding the use 

of tobacco and alcohol, being physically 

active, and demonstrating other positive 

behaviors to achieve and maintain good 

health. Major focus areas include 

preventing and controlling obesity by 

developing and implementing sciencebased nutrition and physical activity 

interventions (i.e., increase 

consumption of fruits and vegetables, 

reduce consumption of foods that are 

high in fat, increase breast feeding, 

reduce television time, and increase 

opportunities for physical activity). 

Other focal areas include preventing the 

consumption of alcohol and tobacco use 

among youth, increasing accessibility to 

tobacco cessation programs, and 

reducing exposure to second-hand 

smoke. 

The HP/DP initiative encourages 

Tribal applicants to fully engage their 

local schools, communities, health care 

providers, health centers, faith-based/ 

spiritual communities, elderly centers, 

youth programs, local governments, 

academia, non-profit organizations, and 

many other community sectors to work 

together to enhance and promote health 

and prevent chronic disease in their 

communities. The initiative is described 

in the Catalog of Federal Domestic 

mstockstill on PROD1PC66 with NOTICES